fusidic acid has been researched along with chlorhexidine in 7 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (chlorhexidine) | Trials (chlorhexidine) | Recent Studies (post-2010) (chlorhexidine) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 9,521 | 2,099 | 3,952 |
| Protein | Taxonomy | fusidic acid (IC50) | chlorhexidine (IC50) |
|---|---|---|---|
| perilipin-5 | Homo sapiens (human) | 4.0045 | |
| perilipin-1 | Homo sapiens (human) | 2.2083 | |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 2.6045 | |
| melanocortin receptor 4 | Homo sapiens (human) | 1.997 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 3.5425 | |
| hexokinase HKDC1 | Homo sapiens (human) | 8.99 | |
| Synaptojanin-2 | Homo sapiens (human) | 10 | |
| Solute carrier family 22 member 2 | Homo sapiens (human) | 0.4 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 0.21 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.41 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 7.63 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 7.63 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 0.5 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Byron, MP; Carruth, WA; Hampton, AA; Sherertz, RJ; Solomon, DD | 1 |
| Celiköz, B; Karagoz, H; Oncul, O; Ulkür, E; Yeniz, E | 1 |
| Andrews, GP; Gorman, SP; Jones, DS | 1 |
| Bond, R; Clark, SM; Loeffler, A | 1 |
| Berthelot, P; Botelho-Nevers, E; Carricajo, A; Gavid, M; Grattard, F; He, Z; Lelonge, Y; Morgene, MF; Pozzetto, B; Rigaill, J; Verhoeven, PO | 1 |
| Bond, R; Frosini, SM; Grönthal, T; Lindsay, J; Loeffler, A; O'Shea, K; Rankin, SC; Rantala, M; Schmidt, V; Timofte, D | 1 |
| Brown, M; Dempsey, K; Kok, J; Li, C; Nahidi, S; O'Sullivan, MVN; Ramsperger, M; Shaban, RZ; Sotomayor-Castillo, C | 1 |
7 other study(ies) available for fusidic acid and chlorhexidine
| Article | Year |
|---|---|
Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits.
Topics: Animals; Anti-Bacterial Agents; Catheterization; Catheters, Indwelling; Chlorhexidine; Ciprofloxacin; Clindamycin; Dicloxacillin; Fusidic Acid; Half-Life; Rabbits; Staphylococcal Infections | 1993 |
Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bandages; Burns; Chlorhexidine; Drug Therapy, Combination; Fusidic Acid; Male; Methicillin Resistance; Polyesters; Polyethylenes; Random Allocation; Rats; Rats, Wistar; Staphylococcal Skin Infections; Staphylococcus aureus | 2005 |
Characterization of crosslinking effects on the physicochemical and drug diffusional properties of cationic hydrogels designed as bioactive urological biomaterials.
Topics: Anti-Infective Agents; Chemistry, Pharmaceutical; Chlorhexidine; Coated Materials, Biocompatible; Cross-Linking Reagents; Delayed-Action Preparations; Equipment and Supplies; Female; Fusidic Acid; Humans; Hydrogels; Hydrogen-Ion Concentration; Nitriles; Polymethyl Methacrylate; Time Factors; Urinary Catheterization | 2005 |
Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Chlorhexidine; Dog Diseases; Dogs; Drug Synergism; Fusidic Acid; Germany; Miconazole; Microbial Sensitivity Tests; Pyoderma; Staphylococcal Skin Infections; Staphylococcus; United Kingdom | 2015 |
Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Carrier State; Cell Line; Chlorhexidine; Cytoplasm; Epithelial Cells; Fusidic Acid; Humans; Keratinocytes; Nasal Mucosa; Staphylococcus aureus | 2018 |
Genetic resistance determinants to fusidic acid and chlorhexidine in variably susceptible staphylococci from dogs.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Chlorhexidine; Disinfectants; Dogs; Drug Resistance, Multiple, Bacterial; Finland; Fusidic Acid; Germany; Methicillin Resistance; Microbial Sensitivity Tests; Peptide Elongation Factor G; Pyoderma; R Factors; Staphylococcus; Staphylococcus aureus; United States | 2019 |
Outbreak of community-acquired Staphylococcus aureus skin infections in an Australian professional football team.
Topics: Administration, Intranasal; Anti-Bacterial Agents; Anti-Infective Agents, Local; Australia; Chlorhexidine; Community-Acquired Infections; Cross-Sectional Studies; Disease Outbreaks; Football; Fusidic Acid; Genome, Bacterial; Humans; Hygiene; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ointments; Retrospective Studies; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2021 |